05.09.2019 - 09.09.2019 19th Congress of International Headache Society (IHC)
At last year’s Congress of the International Headache Society (IHC), migraine took center stage. Entitled “Dawn of new headache treatments”, the meeting focused on novel, targeted, molecular migraine treatments, as well as other emerging therapies.
Cutting edge data in basic and clinical headache research was presented. Additionally, there were teaching courses, plenary sessions, industry symposia, exhibitions, poster sessions and much more. Moreover, the reasons underlying the higher prevalence of migraine in females than in males was addressed in a parallel session on genetic and hormonal factors.